2017 A LOTT of Oxygen: An Update

Long-term oxygen therapy has been proven to improve survival in COPD patients with severely impaired oxygenation. However, does the COPD patient with moderately impaired oxygenation also benefit from supplemental long-term oxygen therapy? The Long-Term Oxygen Treatment Trial (LOTT), a randomized clinical trial published in 2016, was designed to evaluate the efficacy of supplemental oxygen for this patient population. This presentation will discuss the design and results of the multi-center LOTT and the implications on patient care.

This webcast is sponsored by an unrestricted educational grant from ResMed Inc.

ResMed Logo

Presented by Jerry Krishnan MD, PhD

Approved for 1.0 CRCE hour

Original Webcast Date June 6, 2017

**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**

Seminar Information
Seminar Date:
June 06, 2017
Expiration Date:
December 31, 2017 12:00 AM
Seminar Objectives
  • Identify interventions that reduce mortality in COPD
  • Discuss the impact of supplemental oxygen on COPD mortality
  • Discuss the methodology and outcomes of the LOTT study
  • Identify impact of the LOTT study on patient care
2017 A LOTT of Oxygen: An Update
Speaker Information
Jerry Krishnan MD, PhD
Individual topic purchase: Selected
American Association for Respiratory Care
Continuing Respiratory Care Education: 1.00
Products
This seminar is no longer available for purchase.